Rheos Capital Works’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-23,300
Closed -$4.58M 109
2024
Q2
$4.58M Sell
23,300
-45,500
-66% -$9.4M 0.24% 89
2024
Q1
$14.8M Sell
68,800
-53,000
-44% -$11.1M 0.71% 42
2023
Q4
$25.7M Buy
121,800
+66,800
+121% +$14.3M 1.42% 15
2023
Q3
$11M Hold
55,000
0.66% 47
2023
Q2
$10.2M Buy
+55,000
New +$10.2M 0.55% 58

Other funds holding CME

Rheos Capital Works's CME Position: Q3 2024 in Review

Rheos Capital Works sold out of CME Group (CME) in Q3 2024, closing a stake of 23,300 shares — an estimated $4.58M sold.

Rheos Capital Works first reported a position in CME in Q2 2023 and held it in 5 quarters. The position peaked at $25.7M in Q4 2023. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • Rheos Capital Works reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • Rheos Capital Works sold 23,300 CME Group shares in Q3 2024, an estimated $4.58M.
  • Rheos Capital Works first reported a position in CME Group in Q2 2023 and held it in 5 quarters.
  • Rheos Capital Works's CME Group position peaked at $25.7M in Q4 2023.
  • 1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on Rheos Capital Works's 13F filing for Q3 2024, filed 16 Oct 2024.